Sanofi expands immunotherapy portfolio

Sanofi has acquired Kymab, a biopharma immunotherapy company. Under the deal’s terms, the drug manufacturer will purchase Kymab for an upfront payment of approximately $1.1 billion and up to an additional $350 million for completion of specific milestones. Sanofi will […]

Read More

Bayer and CureVac team up on potential vaccine

Bayer has signed an agreement with CureVac N.V., a biopharma company that manufactures medication based on messenger ribonucleic acid (mRNA). Per the deal, Bayer will help with development, supply and territory operations of CureVac’s Covid-19 vaccine candidate, CVnCoV. As of […]

Read More

Clues and connections from the real world

“Encourage your kids to be data scientists,” Jane Quigley, senior VP, digital health, at PRA Health Sciences, offered. Considered one of the “godmothers of real-world data (RWD),” Quigley was underscoring the need today—and great opportunity amid the convergence of technology […]

Read More